Meeting the Moment: How the Opioid Crisis Has Changed the Way We Study, Evaluate and Treat Patients (Session 5)
This is a multi-part information series presented by the University of Virginia Department of Anesthesiology and the Office of Pain Management and Opioid Stewardship:
* View the recording of Session 4 (from May 2) here.
Session 5: Interventional Pain Techniques and Diabetic Neuropathy (8-9pm)
Interventional Pain Procedures – Dr. Priya Singla, UVA Department of Anesthesiology
An estimated 20.9% of U.S. adults (51.6 million people) experience chronic pain, and 6.9% (17.1 million persons) experience high-impact chronic pain (CDC, 2023). Despite multiple trials of medications, therapy, and conservative measures, often a patient’s quality of life has been significantly altered by the pain. Dr. Singla will discuss the assessment process. She will also explore the potential of peripheral nerve and spinal card stimulators and intrathecal pumps for improved patient outcomes.
Diabetic Neuropathy- Dr. Bhavana Yalamuru, UVA Department of Anesthesiology
There are 37.3. million people with diabetes. In the US if effects 11.3 percent of the population. 8.5 million (23% are undiagnosed). This disease has significant complications and associated symptoms. Diabetic neuropathy is a complication from having high sugar levels for a prolonged period of time. Symptoms include pain, increased sensitivity, numbness or weakness and serious foot issues. Dr. Yalamaru will discuss assessment of types of nerve damage and treatments to help patients manage their pain and improve quality of live.